Non-Contraceptive Benefits of Oral Hormonal Contraceptives

Authors

Adolf E Schindler1,*
1Institute for Medical Research and Education, [email protected], Germany
*Corresponding Author: Institute for Medical Research and Education, University Clinic, Hufelandstrasse 55, D-45147, [email protected], Germany. Tel: +49-2017991833. Fax: +49-2017499533. Email: [email protected]

International Journal of Endocrinology and Metabolism:Vol. 11, issue 1; 41-47
Published online:Dec 21, 2012
Article type:Review Article
Received:Jan 15, 2012
Accepted:Jun 23, 2012
How to Cite:Schindler AE. Non-Contraceptive Benefits of Oral Hormonal Contraceptives. Int J Endocrinol Metab. 2012;11(1):. doi: https://doi.org/10.5812/ijem.4158

Abstract

Abstract:

It is becoming evident that oral hormonal contraceptives besides being well established contraceptives seem to become important medications for many functional or organic disturbances. So far, clinical effectiveness has been shown for treatment as well as prevention of menstrual bleeding disorders and menstrual-related pain symptoms. Also this is true for premenstrual syndrome (PMS) and premenstrual disphoric disorder (PMDD).\r\nParticular oral contraceptives (OCs) containing anti-androgenic progestogens were shown to be effective medications for treatment of androgenisation symptoms (seborrhea, acne, hirsutism, alopecia).\r\nThrough perfect suppression of the hypothalamic-pituitary-ovarian axis OCs have proven to be effective in elimination of persistent follicular cysts. Endometriosis/adenomyosis related pain symptoms are well handled similar to other drugs like Gonadotropine Releasing Hormone agonists but are less expensive, with less side effects, and possibility to be used for longer periods of time. This is also true for myoma. Pelvic inflammatory disease, rheumatoid arthritis, menstrual migraine, and onset of multiple sclerosis are prevented or delayed. Bone density is preserved and asthma symptoms improved. Endometrial hyperplasia and benign breast disease can be controlled. There is definitely a significant impact on risk reduction regarding endometrial, ovarian, and colon cancers.\r\nIn conclusion, it needs to be recognized that oral combined hormonal contraceptives (estrogen/ progestogen combination) are besides being reliable forms of contraception are cost-effective medications for many medical disorders in women. Therefore, these contraceptives drugs are important for female and global health and should be used in clinical practice.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

24
Jul
2009

Incidence of Abnormal Uterine Bleeding in individuals who used hormonal contraceptive methods and referred to Semnan health centers (2006-2007)

Sanam Moradan,
Somayeh Baghani,
Raheb Ghorbani

Moradan S, Baghani S, Ghorbani R. Incidence of Abnormal Uterine Bleeding in individuals who used hormonal contraceptive methods and referred to Semnan health centers (2006-2007). koomesh. 2009;10(3):e152244. doi:

20
Apr
2012

An Update on Plant Derived Anti-Androgens

Paul Grant,
Shamin Ramasamy

Grant P, Ramasamy S. An Update on Plant Derived Anti-Androgens. Int J Endocrinol Metab. 2012;10(2):. doi: https://doi.org/10.5812/ijem.3644

14
Oct
2020
The Menstrual Disturbances in Endocrine Disorders: A Narrative Review

The Menstrual Disturbances in Endocrine Disorders: A Narrative Review

Marzieh Saei Ghare Naz,
Marzieh Rostami Dovom,
Fahimeh Ramezani Tehrani

Saei Ghare Naz M, Rostami Dovom M, Ramezani Tehrani F. The Menstrual Disturbances in Endocrine Disorders: A Narrative Review. Int J Endocrinol Metab. 2020;18(4):e106694. doi: https://doi.org/10.5812/ijem.106694

31
Mar
2013

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome

Pilar Alama,
Jose Bellver,
Carmen Vidal,
Juan Giles

Alama P, Bellver J, Vidal C, Giles J. GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome. Int J Endocrinol Metab. 2013;11(2):. doi: https://doi.org/10.5812/ijem.5034

30
Jun
2007

Differential effectiveness of hormone replacement therapy and relaxation techniques on consequences of menopause vasomotor symptoms

S Kamali,
N MosaviNasab

Kamali S, MosaviNasab N. Differential effectiveness of hormone replacement therapy and relaxation techniques on consequences of menopause vasomotor symptoms. J Inflamm Dis. 2024;11(1):e155289. doi:

More by these authors

Adolf E SchindlerPubMedScholar
Share
Cited by
Metrics